1. Home
  2. ZVRA vs NXP Comparison

ZVRA vs NXP Comparison

Compare ZVRA & NXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$11.13

Market Cap

653.2M

Sector

Health Care

ML Signal

HOLD

Logo Nuveen Select Tax Free Income Portfolio

NXP

Nuveen Select Tax Free Income Portfolio

HOLD

Current Price

$14.33

Market Cap

744.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZVRA
NXP
Founded
2006
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
653.2M
744.2M
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
ZVRA
NXP
Price
$11.13
$14.33
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$23.00
N/A
AVG Volume (30 Days)
1.1M
150.4K
Earning Date
05-06-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
159.21
N/A
EPS
0.60
N/A
Revenue
$106,470,000.00
N/A
Revenue This Year
$37.27
N/A
Revenue Next Year
$53.42
N/A
P/E Ratio
$18.52
N/A
Revenue Growth
350.91
N/A
52 Week Low
$7.16
$13.73
52 Week High
$13.16
$14.65

Technical Indicators

Market Signals
Indicator
ZVRA
NXP
Relative Strength Index (RSI) 62.20 54.44
Support Level $8.30 $14.27
Resistance Level $12.14 $14.56
Average True Range (ATR) 0.57 0.15
MACD 0.07 0.03
Stochastic Oscillator 69.60 72.92

Price Performance

Historical Comparison
ZVRA
NXP

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

About NXP Nuveen Select Tax Free Income Portfolio

Nuveen Select Tax Free Income Portfolio is a closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax, consistent with preservation of capital. The fund invests a majority of its assets in municipal securities and other related investments, the income from which is exempt from regular federal income tax and federal alternative minimum tax.

Share on Social Networks: